In-depth country-focused analysis on Africa's economic, political and operational risk environment,
complemented by detailed sector insight


A Challenging Market For Innovative Drugmakers

As one of the smaller pharmaceutical markets in Sub-Saharan Africa, Gabon will continue to be viewed as a relatively unattractive destination for the sale of high-value drugs by innovative drugmakers. The market dynamics are robust, however, as the gradual transition towards a chronic-disease dominated landscape is indicative of the increasing prevalence of lifestyle-related diseases in Gabon.





Download the Monthly Outlook

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your downloading the monthly outlook.